Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-08-31

Study Completion Date

2005-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare levofloxacin vs ceftriaxone impact on the cytokine production in patients with pneumococcal pneumonia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of the Safety and Effectiveness of Levofloxacin Compared With Ceftriaxone Sodium or Cefuroxime Axetil in the Treatment of Adults With Pneumonia

NCT00257049

Pneumonia

COMPLETED PHASE2/PHASE3

Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia

NCT01524302

Pneumonia, Bacterial Community-acquired

COMPLETED PHASE4

Pharmacokinetics of Levofloxacin in Intensive Care Unit

NCT02018081

Intensive Care Unit Syndrome Community-acquired Pneumonia

COMPLETED PHASE4

Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients

NCT02600806

Community-acquired Pneumonia

UNKNOWN PHASE4

A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization

NCT00236834

Nosocomial Pneumonia

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bacterial alveolar invasion is followed by a compartmentalized inflammatory response. Data suggest that some antimicrobials may induce a differential release of cytokines, with the potential of either accelerating or down regulating cytokine production.

The aim of our study was to compare the effects of ceftriaxone compared with levofloxacin on cytokine systemic concentrations in patients with pneumococcal pneumonia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia, Pneumococcal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

levofloxacin

Intervention Type DRUG

ceftriaxone

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with an acute febrile respiratory illness accompanied by a new radiographic infiltrate consistent with this diagnosis.
* and with a confirmed pneumococcal aetiology

Exclusion Criteria

* age \< 18 years,
* pneumonia distal to endobronchial obstruction,
* pulmonary tuberculosis,
* bronchiectasis,
* known allergy to B-lactams or fluoroquinolones,
* underlying systemic autoimmune disease
* immunocompromised states including patients on maintenance oral corticosteroids, HIV infection,
* pregnancy,
* patients that received antimicrobial therapy in the 15 days preceding the current episode and those who had received fluoroquinolones in the last month, or non steroidal anti-inflammatory therapy in the last two weeks.
* Patients with renal failure (serum creatinine \> 2 mg / dL),
* and patients with a documented pneumococcal pneumonia in the previous 4 weeks

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No